Role of Neuroinflammation in Autism Spectrum Disorder and the Emergence of Brain Histaminergic System. Lessons Also for BPSD?

Alzheimer’s disease H3R antagonists autism spectrum disorder behavioral and psychological symptoms of dementia central histamine receptors cytokines neuroinflammation schizophrenia

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2020
Historique:
received: 18 12 2019
accepted: 29 05 2020
entrez: 3 7 2020
pubmed: 3 7 2020
medline: 3 7 2020
Statut: epublish

Résumé

Many behavioral and psychological symptoms of dementia (BPSD) share similarities in executive functioning and communication deficits with those described in several neuropsychiatric disorders, including Alzheimer's disease (AD), epilepsy, schizophrenia (SCH), and autism spectrum disorder (ASD). Numerous studies over the last four decades have documented altered neuroinflammation among individuals diagnosed with ASD. The purpose of this review is to examine the hypothesis that central histamine (HA) plays a significant role in the regulation of neuroinflammatory processes of microglia functions in numerous neuropsychiatric diseases, i.e., ASD, AD, SCH, and BPSD. In addition, this review summarizes the latest preclinical and clinical results that support the relevance of histamine H1-, H2-, and H3-receptor antagonists for the potential clinical use in ASD, SCH, AD, epilepsy, and BPSD, based on the substantial symptomatic overlap between these disorders with regards to cognitive dysfunction. The review focuses on the histaminergic neurotransmission as relevant in these brain disorders, as well as the effects of a variety of H3R antagonists in animal models and in clinical studies.

Identifiants

pubmed: 32612529
doi: 10.3389/fphar.2020.00886
pmc: PMC7309953
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

886

Informations de copyright

Copyright © 2020 Eissa, Sadeq, Sasse and Sadek.

Références

Int J Mol Sci. 2020 Feb 07;21(3):
pubmed: 32046139
Br J Pharmacol. 2008 Jul;154(6):1166-81
pubmed: 18469850
Inflamm Res. 2004 Mar;53 Suppl 1:S49-50
pubmed: 15054614
Pharmacol Biochem Behav. 2012 Aug;102(2):203-14
pubmed: 22542742
Autism Res. 2018 Aug;11(8):1110-1119
pubmed: 30284394
Schizophr Res. 2018 Sep;199:281-284
pubmed: 29499967
Schizophr Bull. 2006 Oct;32 Suppl 1:S44-63
pubmed: 16916889
Neuropharmacology. 2016 Jul;106:85-90
pubmed: 26282120
Curr Protoc Toxicol. 2011 Nov;Chapter 12:Unit12.19
pubmed: 22058053
CNS Drugs. 2012 May 1;26(5):421-34
pubmed: 22519922
Neuropsychiatr Dis Treat. 2019 Feb 20;15:531-542
pubmed: 30863075
J Med Chem. 2011 Jan 13;54(1):26-53
pubmed: 21062081
Drug Des Devel Ther. 2016 Nov 25;10:3879-3898
pubmed: 27932863
Biol Psychiatry. 2010 Feb 1;67(3):283-6
pubmed: 19880096
Am J Med Genet A. 2015 Apr;167A(4):715-23
pubmed: 25655306
Pediatr Neurol. 2007 Jun;36(6):361-5
pubmed: 17560496
Biol Psychiatry. 2008 Apr 15;63(8):801-8
pubmed: 18005941
J Neuroimmunol. 2009 Feb 15;207(1-2):111-6
pubmed: 19157572
J Neural Transm (Vienna). 2001;108(5):593-611
pubmed: 11459079
Clin Neurosci Res. 2006 Dec;6(5):237-245
pubmed: 19169437
Neuroscientist. 2005 Oct;11(5):417-40
pubmed: 16151044
J Autism Dev Disord. 2007 Apr;37(4):605-12
pubmed: 16909311
Curr Alzheimer Res. 2017;14(4):412-425
pubmed: 27697064
Epilepsy Behav. 2013 Jul;28(1):66-70
pubmed: 23665640
Biochem Pharmacol. 2007 Apr 15;73(8):1215-24
pubmed: 17343831
Chem Biol Interact. 2019 Dec 1;314:108823
pubmed: 31563592
J Neuroimmune Pharmacol. 2020 Jun;15(2):280-291
pubmed: 31863333
J Autism Dev Disord. 2001 Feb;31(1):19-28
pubmed: 11439750
Med Hypotheses. 1997 May;48(5):381-6
pubmed: 9185122
J Autism Dev Disord. 2018 Sep;48(9):3086-3092
pubmed: 29654453
Tijdschr Gerontol Geriatr. 2018 Oct;49(5):187-205
pubmed: 30238286
Med Hypotheses. 2016 Mar;88:74-8
pubmed: 26880644
Front Psychiatry. 2019 Apr 10;10:165
pubmed: 31024350
Front Psychiatry. 2020 Feb 20;11:46
pubmed: 32153436
Trends Neurosci. 2008 Jul;31(7):361-70
pubmed: 18538868
Expert Opin Pharmacother. 2017 Apr;18(6):581-588
pubmed: 28335658
Int Rev Neurobiol. 2006;72:245-64
pubmed: 16697302
J Autism Dev Disord. 2016 Mar;46(3):1071-83
pubmed: 26572659
Biol Psychiatry. 2007 Feb 15;61(4):458-64
pubmed: 17137564
Mol Neurobiol. 2018 Jan;55(1):312-321
pubmed: 28861757
Am J Clin Nutr. 2009 Jan;89(1):425-30
pubmed: 19056591
Eur J Neurosci. 2010 Feb;31(3):544-55
pubmed: 20105240
Arch Pediatr Adolesc Med. 2007 Apr;161(4):326-33
pubmed: 17404128
J Psychiatr Res. 2013 Jun;47(6):783-90
pubmed: 23453820
Neurobiol Dis. 2008 Jun;30(3):303-11
pubmed: 18378158
Eur Psychiatry. 2002 Jul;17(4):230-1
pubmed: 12231270
Hum Mol Genet. 2012 Aug 1;21(15):3513-23
pubmed: 22543975
J Med Genet. 2013 Nov;50(11):760-4
pubmed: 23825391
J Pharmacol Exp Ther. 2005 Apr;313(1):176-90
pubmed: 15608077
Front Pharmacol. 2019 May 22;10:540
pubmed: 31191302
Transl Psychiatry. 2017 Jan 10;7(1):e999
pubmed: 28072412
Front Neurosci. 2018 Feb 12;12:42
pubmed: 29483860
Lancet. 2014 Mar 8;383(9920):896-910
pubmed: 24074734
JAMA. 2003 Jul 16;290(3):337-44
pubmed: 12865374
Sci Rep. 2019 Jun 10;9(1):8384
pubmed: 31182747
Autism Res. 2014 Apr;7(2):273-89
pubmed: 24124122
Sci Rep. 2018 Aug 30;8(1):13077
pubmed: 30166610
Mol Psychiatry. 2015 Apr;20(4):440-6
pubmed: 24934179
J Neurol Neurosurg Psychiatry. 2003 Oct;74(10):1364-70
pubmed: 14570827
Arch Gen Psychiatry. 2004 Jun;61(6):618-27
pubmed: 15184241
Neurosci Bull. 2016 Oct;32(5):469-80
pubmed: 27568024
Brain Res Bull. 2002 Jan 1;57(1):109-19
pubmed: 11827743
J Clin Pharm Ther. 2004 Apr;29(2):145-50
pubmed: 15068403
J Autism Dev Disord. 2014 Oct;44(10):2547-57
pubmed: 24803367
J Toxicol Environ Health B Crit Rev. 2006 Nov-Dec;9(6):485-99
pubmed: 17090484
Pharmacol Ther. 2004 Jul;103(1):1-20
pubmed: 15251226
J Pharmacol Exp Ther. 2011 Feb;336(2):479-87
pubmed: 21057059
Front Cell Neurosci. 2014 Apr 30;8:120
pubmed: 24817841
Schizophr Bull. 2006 Apr;32(2):214-9
pubmed: 16481659
J Alzheimers Dis. 2018;64(s1):S313-S327
pubmed: 29710716
JAMA. 2018 Jan 2;319(1):81-82
pubmed: 29297068
Arch Gen Psychiatry. 2011 Nov;68(11):1095-102
pubmed: 21727249
Front Psychiatry. 2019 Feb 21;10:78
pubmed: 30846948
PLoS One. 2015 Jan 05;10(1):e0116363
pubmed: 25560049
Curr Dev Disord Rep. 2014 Mar 1;1(1):20-28
pubmed: 25072016
Transl Psychiatry. 2017 May 9;7(5):e1126
pubmed: 28485729
Alcohol Clin Exp Res. 2010 Oct;34(10):1793-802
pubmed: 20626729
Bioorg Med Chem Lett. 2009 Jan 15;19(2):538-42
pubmed: 19091563
Clin Psychopharmacol Neurosci. 2017 Aug 31;15(3):229-236
pubmed: 28783931
Nat Genet. 2008 Dec;40(12):1466-71
pubmed: 19029900
Int J Neurosci. 2017 Jul;127(7):624-633
pubmed: 27412492
Arch Gen Psychiatry. 2009 Sep;66(9):947-56
pubmed: 19736351
Brain. 2018 Mar 1;141(3):626-628
pubmed: 30753416
J Clin Psychiatry. 2005;66 Suppl 10:26-31
pubmed: 16401147
Transl Psychiatry. 2016 Jun 28;6(6):e844
pubmed: 27351598
CNS Neurol Disord Drug Targets. 2016;15(4):390-402
pubmed: 26996178
Neuron. 2014 Jan 8;81(1):77-90
pubmed: 24411733
Life Sci. 2017 Jul 1;180:23-35
pubmed: 28501482
Behav Brain Res. 2009 Dec 1;204(1):217-25
pubmed: 19527754
Curr Opin Infect Dis. 2006 Jun;19(3):290-7
pubmed: 16645492
Neuropharmacology. 2016 Jul;106:56-73
pubmed: 26581501
Neurotherapeutics. 2010 Jul;7(3):293-301
pubmed: 20643382
Curr Neurol Neurosci Rep. 2015 Apr;15(4):17
pubmed: 25716012
Behav Brain Res. 2004 Aug 12;153(1):69-76
pubmed: 15219708
J Child Psychol Psychiatry. 2018 Jul;59(7):744-751
pubmed: 29377119
Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1500-5
pubmed: 9037082
Neuropsychiatr Dis Treat. 2013;9:1443-55
pubmed: 24092982
Trends Cogn Sci. 2011 Mar;15(3):132-9
pubmed: 21273114
J Child Neurol. 1999 Aug;14(8):547-50
pubmed: 10456769
Int Arch Allergy Immunol. 2005 May;137(1):82-92
pubmed: 15832054
Neuron. 2014 Aug 6;83(3):518-32
pubmed: 25102558
Curr Alzheimer Res. 2014 Jan;11(1):47-58
pubmed: 24359500
Neuropharmacology. 2016 Jul;106:46-55
pubmed: 26525191
J Pharmacol Exp Ther. 1998 Nov;287(2):658-66
pubmed: 9808693
JAMA Psychiatry. 2017 Nov 1;74(11):1120-1128
pubmed: 28877317
Curr Alzheimer Res. 2013 Mar;10(3):240-51
pubmed: 23521503
Brain Behav Immun. 2009 Jan;23(1):116-23
pubmed: 18755264
J Autism Dev Disord. 2007 Apr;37(4):628-36
pubmed: 16977497
J Psychopharmacol. 2014 Jul;28(7):677-85
pubmed: 24132248
Front Cell Neurosci. 2016 Jan 19;9:519
pubmed: 26834565
J Med Chem. 2000 Oct 19;43(21):3987-94
pubmed: 11052804
Ann Neurol. 2005 Jan;57(1):67-81
pubmed: 15546155
Asian J Psychiatr. 2018 Oct;37:78-79
pubmed: 30149284
Psychopharmacology (Berl). 2015 Jan;232(1):165-72
pubmed: 24958229
Sci Adv. 2017 Jun 21;3(6):e1603001
pubmed: 28691086
Pediatrics. 2004 May;113(5):e472-86
pubmed: 15121991
Br J Psychiatry. 2017 Apr;210(4):241-242
pubmed: 28373219
Immunol Rev. 2006 Oct;213:48-65
pubmed: 16972896
J Clin Med. 2019 Feb 08;8(2):
pubmed: 30744008
Trends Pharmacol Sci. 2011 Apr;32(4):242-9
pubmed: 21324537
Dev Neurosci. 2017;39(5):355-360
pubmed: 28750400
J Neuroinflammation. 2017 Sep 4;14(1):179
pubmed: 28870209
Transl Psychiatry. 2012 Sep 04;2:e158
pubmed: 22948383
J Pharmacol Exp Ther. 2007 Jun;321(3):1032-45
pubmed: 17327487
Med Hypotheses. 2017 Mar;100:64-66
pubmed: 28236851
N Engl J Med. 2008 Feb 14;358(7):667-75
pubmed: 18184952
Pediatr Res. 2011 May;69(5 Pt 2):26R-33R
pubmed: 21289540
J Psychiatr Res. 2019 Aug;115:36-42
pubmed: 31102902
Pharmacol Rev. 2015 Jul;67(3):601-55
pubmed: 26084539
Biochem Pharmacol. 2007 Apr 15;73(8):1182-94
pubmed: 17276409
J Alzheimers Dis. 2014;42(3):959-71
pubmed: 25024314
Neurotoxicol Teratol. 2013 Mar-Apr;36:67-81
pubmed: 22918031
Arzneimittelforschung. 2012 May;62(5):222-9
pubmed: 22331799
Neuroimmunomodulation. 2018;25(5-6):285-299
pubmed: 30157484
Int J Neuropsychopharmacol. 2013 May;16(4):889-904
pubmed: 22906530
Mol Neurobiol. 2014 Jun;49(3):1487-500
pubmed: 24752587
Mol Autism. 2017 Mar 21;8:14
pubmed: 28344757
Neurosci Lett. 2019 Jun 21;704:36-44
pubmed: 30946928
Chem Biol Interact. 2019 Oct 1;312:108775
pubmed: 31369746
Schizophr Bull. 2014 Nov;40(6):1433-42
pubmed: 24516190
J Autism Dev Disord. 2006 Oct;36(7):901-9
pubmed: 16897395
Genome Med. 2009 Oct 30;1(10):102
pubmed: 19886976
Neurobiol Learn Mem. 2011 Jan;95(1):64-72
pubmed: 21073971
Int Rev Neurobiol. 2013;112:155-77
pubmed: 24295621
J Neuroinflammation. 2012 May 08;9:90
pubmed: 22569158
Neuropharmacology. 2009 Jun;56(8):1131-7
pubmed: 19345233
Pharmacol Biochem Behav. 2010 Mar;95(1):41-50
pubmed: 20004681
Ann Gen Psychiatry. 2014 Nov 18;13(1):34
pubmed: 25426159
Mol Cytogenet. 2012 Jun 11;5(1):30
pubmed: 22686481
Hum Mol Genet. 2010 Sep 1;19(17):3477-81
pubmed: 20587603
Nature. 2008 Sep 11;455(7210):232-6
pubmed: 18668039
Brain Behav Immun. 2016 Oct;57:326-337
pubmed: 27381299
J Neuropsychol. 2020 Mar 25;:
pubmed: 32212244
Biol Psychiatry. 2012 Mar 1;71(5):392-402
pubmed: 22169095
Dialogues Clin Neurosci. 2007;9(2):161-71
pubmed: 17726915
J Pharmacol Exp Ther. 2016 Sep;358(3):504-15
pubmed: 27384073
Biochim Biophys Acta Mol Basis Dis. 2017 Mar;1863(3):764-769
pubmed: 28057587
Pediatrics. 2011 Aug;128(2):344-55
pubmed: 21746727
PLoS Genet. 2010 May 20;6(5):e1000962
pubmed: 20502679
Clin Neuropharmacol. 2010 May;33(3):114-20
pubmed: 20190638
Nat Neurosci. 2010 Oct;13(10):1161-9
pubmed: 20877280
Brain Behav Immun. 2011 Nov;25(8):1582-91
pubmed: 21640817
Nat Genet. 2009 Nov;41(11):1223-7
pubmed: 19855392
Behav Brain Res. 2008 Mar 5;187(2):207-20
pubmed: 17983671
Brain Sci. 2017 Oct 26;7(11):
pubmed: 29072583
Am J Hum Genet. 2012 May 4;90(5):879-87
pubmed: 22503632
Alzheimer Dis Assoc Disord. 2020 Jan-Mar;34(1):66-71
pubmed: 31517641
Behav Brain Res. 2016 Oct 1;312:415-30
pubmed: 27363923
PLoS Genet. 2012 Feb;8(2):e1002521
pubmed: 22346768
Mech Ageing Dev. 2006 Feb;127(2):158-65
pubmed: 16297434
J Child Neurol. 2014 Dec;29(12):1645-51
pubmed: 24413357
Neuropsychopharmacology. 2014 Mar;39(4):831-40
pubmed: 24096295
Front Neurol. 2012 May 07;3:73
pubmed: 22586419
Biochem Biophys Res Commun. 2017 Jul 1;488(3):534-540
pubmed: 28526411
Acta Psychiatr Scand. 2000 Nov;102(5):321-30
pubmed: 11098802
Mol Cell Neurosci. 2013 Mar;53:69-76
pubmed: 23069728
Aging Ment Health. 2011 Mar;15(2):157-68
pubmed: 21140304
Front Immunol. 2017 Nov 30;8:1689
pubmed: 29250069
Acta Obstet Gynecol Scand. 2012 Mar;91(3):287-300
pubmed: 22085436
Psychopharmacology (Berl). 2015 Dec;232(23):4303-16
pubmed: 26337613
J Alzheimers Dis. 2015;50(2):591-604
pubmed: 26836635
CNS Drugs. 2011 Jul;25(7):597-606
pubmed: 21699271
Neurobiol Learn Mem. 2017 Nov;145:1-6
pubmed: 28838882
Front Psychiatry. 2019 Dec 06;10:892
pubmed: 31908647
Exp Dermatol. 2012 Jan;21(1):32-7
pubmed: 22151388
Curr Pharm Des. 2015;21(26):3760-70
pubmed: 26044979
J Nerv Ment Dis. 2015 May;203(5):393-9
pubmed: 25919386
Cerebellum. 2014 Feb;13(1):151-77
pubmed: 23996631

Auteurs

Nermin Eissa (N)

Department of Pharmacology and Therapeutics, College of Medicine & Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
Zayed Center for Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.

Adel Sadeq (A)

College of Pharmacy, Al Ain University of Science and Technology, Al Ain, United Arab Emirates.

Astrid Sasse (A)

School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, University of Dublin, Dublin, Ireland.

Bassem Sadek (B)

Department of Pharmacology and Therapeutics, College of Medicine & Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
Zayed Center for Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.

Classifications MeSH